Cargando...
Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study
BACKGROUND: Limited prospective data are available on the long-term safety of darbepoetin alfa (DA) for treating anemia in children with chronic kidney disease (CKD). METHODS: In this prospective, phase IV, observational registry study, children ≤16 years of age with CKD anemia and receiving DA were...
Gardado en:
| Publicado en: | Pediatr Nephrol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4756039/ https://ncbi.nlm.nih.gov/pubmed/26482252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-015-3225-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|